Compare PRZO & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRZO | NAII |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1M | 21.2M |
| IPO Year | 2023 | 1987 |
| Metric | PRZO | NAII |
|---|---|---|
| Price | $1.05 | $3.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 604.9K | 15.7K |
| Earning Date | 03-20-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,007,440.00 | ★ $135,157,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.42 | 10.92 |
| 52 Week Low | $0.53 | $2.57 |
| 52 Week High | $2.15 | $4.96 |
| Indicator | PRZO | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 39.99 |
| Support Level | $0.93 | $3.07 |
| Resistance Level | $1.13 | $4.22 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 28.47 | 24.14 |
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.